Skip to main content
. 2021 Mar 26;3(2):e200061. doi: 10.1148/rycan.2021200061

Figure 5:

Kaplan-Meier survival curves of disease-free survival on the basis of whole-body diffusion-weighted (WB-DWI) MRI and interim and end-of treatment fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT assessment of treatment response.

Kaplan-Meier survival curves of disease-free survival on the basis of whole-body diffusion-weighted (WB-DWI) MRI and interim and end-of treatment fluorine 18 (18F) fluorodeoxyglucose (FDG) PET/CT assessment of treatment response.